Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000168

Chairperson & CEO sold 9,500 shares at an average $553.87 ($5,261,741)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

18 lines
Date Transaction Shares Price Value Owned after D/I
2026-10-20 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $117.76 $1,118,720 333,943 I
2026-10-20 Sale : show line 2 in the form 10b5-1 −117 $546.84 $63,981 333,826 I
2026-10-20 Sale : show line 3 in the form 10b5-1 −575 $547.79 $314,977 333,251 I
2026-10-20 Sale : show line 4 in the form 10b5-1 −948 $548.95 $520,400 332,303 I
2026-10-20 Sale : show line 5 in the form 10b5-1 −586 $550.02 $322,311 331,717 I
2026-10-20 Sale : show line 6 in the form 10b5-1 −1,134 $551.03 $624,870 330,583 I
2026-10-20 Sale : show line 7 in the form 10b5-1 −1,560 $551.85 $860,883 329,023 I
2026-10-20 Sale : show line 8 in the form 10b5-1 −240 $553.14 $132,754 328,783 I
Open-market sales · 9,500 sh · avg $553.87 · $5,261,741

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-10-20 Exercise or conversion : show line 19 in the form 10b5-1 Stock Option −9,500 195,410 I
Loading xslF345X06/primarydocument.xml…